Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy

JACC: Heart Failure

Volumn 3, Issue 11, 2015, Pages 906-916

  Shore, Supriya ^a   Grau Sepulveda, Maria V ^b   Bhatt, Deepak L ^c   Heidenreich, Paul A ^d   Eapen, Zubin J ^b   Hernandez, Adrian F ^b   Yancy, Clyde W ^e   Fonarow, Gregg C ^f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d STANFORD UNIVERSITY   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HF etiology; ischemic cardiomyopathy; nonischemic cardiomyopathy; outcome

Indexed keywords

AGED; CARDIOMYOPATHIES; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; EPIDEMIOLOGY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOMYOPATHIES; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84984830673     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.06.012     Document Type: Article

References (29)

1. Roger, V.L., Epidemiology of heart failure. Circ Res 113 (2013), 646–659.
2. McCullough, P.A., Philbin, E.F., Spertus, J.A., et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39 (2002), 60–69.
3. Gheorghiade, M., Bonow, R.O., Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97 (1998), 282–289.
4. Baldasseroni, S., Opasich, C., Gorini, M., et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 143 (2002), 398–405.
5. Follath, F., Nonischemic heart failure: epidemiology, pathophysiology, and progression of disease. J Cardiovasc Pharmacol 33:Suppl 3 (1999), S31–S35.
6. LaBresh, K.A., Ellrodt, A.G., Gliklich, R., Liljestrand, J., Peto, R., Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med 164 (2004), 203–209.
7. Ho, K.K., Pinsky, J.L., Kannel, W.B., Levy, D., The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22 (1993), 6A–13A.
8. Dunlay, S.M., Weston, S.A., Jacobsen, S.J., Roger, V.L., Risk factors for heart failure: a population-based case-control study. Am J Med 122 (2009), 1023–1028.
9. He, J., Ogden, L.G., Bazzano, L.A., Vupputuri, S., Loria, C., Whelton, P.K., Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161 (2001), 996–1002.
10. Levy, D., Larson, M.G., Vasan, R.S., Kannel, W.B., Ho, K.K., The progression from hypertension to congestive heart failure. JAMA 275 (1996), 1557–1562.
11. Bourassa, M.G., Gurne, O., Bangdiwala, S.I., et al., for the SOLVD Investigators. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 22 (1993), 14A–19A.
12. DiBianco, R., Shabetai, R., Kostuk, W., Moran, J., Schlant, R.C., Wright, R., A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 320 (1989), 677–683.
13. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997), 525–533.
14. Hudson, L., Morales, A., Mauro, A.C., et al. Family history of dilated cardiomyopathy among patients with heart failure from the HF-ACTION genetic ancillary study. Clin Transl Sci 6 (2013), 179–183.
15. Teerlink, J.R., Goldhaber, S.Z., Pfeffer, M.A., An overview of contemporary etiologies of congestive heart failure. Am Heart J 121 (1991), 1852–1853.
16. Cowie, M.R., Wood, D.A., Coats, A.J., et al. Incidence and aetiology of heart failure; a population-based study. Eur Heart J 20 (1999), 421–428.
17. Fox, K.F., Cowie, M.R., Wood, D.A., et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 22 (2001), 228–236.
18. Kannel, W.B., Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 275 (1996), 1571–1576.
19. Elliott, P.M., Classification of cardiomyopathies: evolution or revolution?. J Am Coll Cardiol 62 (2013), 2073–2074.
20. Elliott, P., Andersson, B., Arbustini, E., et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29 (2008), 270–276.
21. Maron, B.J., Towbin, J.A., Thiene, G., et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006), 1807–1816.
22. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157 (1997), 2413–2446.
23. Meissner, I., Whisnant, J.P., Sheps, S.G., et al. Detection and control of high blood pressure in the community: do we need a wake-up call?. Hypertension 34 (1999), 466–471.
24. Piano, M.R., Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 121 (2002), 1638–1650.
25. Burkett, E.L., Hershberger, R.E., Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 45 (2005), 969–981.
26. Codd, M.B., Sugrue, D.D., Gersh, B.J., Melton, L.J. 3rd, Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 80 (1989), 564–572.
27. Goerss, J.B., Michels, V.V., Burnett, J., et al. Frequency of familial dilated cardiomyopathy. Eur Heart J 16:Suppl O (1995), 2–4.
28. Curtis, L.H., Greiner, M.A., Hammill, B.G., et al. Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients. Circ Cardiovasc Qual Outcomes 2 (2009), 377–384.
29. Arbustini, E., Narula, N., Dec, G.W., et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. Glob Heart 8 (2013), 355–382.